Pereiti prie turinio
HPB-ALL
Audinys
Peripheral blood
Liga
Precursor T-cell acute lymphoblastic leukemia
Metastazių vieta
Peripheral blood (systemic T-ALL)
Sinonimai
HPB/ALL, HPBALL, FCCH1018

Dokumentai

HPB-ALL

Cell line · Prekės numeris 302895

HPB-ALL – tai žmogaus T-limfoblastinės leukemijos (T-ALL) pirmtakinių T-ląstelių ląstelių linija, išskirta iš 14-mečio japonų berniuko periferinio kraujo...

€430.00neįskaitant mokesčių ir pristatymo išlaidų

Pritaikymas / Rekomendacijos

Yra sandėlyje
Lot
Rekomenduojama (šviežiausia partija)
  • CoA
1

01Bendra informacija

Aprašymas

HPB-ALL is a human precursor T-cell acute lymphoblastic leukemia (T-ALL) cell line established from the peripheral blood of a 14-year-old Japanese male patient. The line grows in suspension with lymphocyte-like morphology. HPB-ALL harbors a complex TP53 mutational profile with eight mutations across heterozygous and homozygous states, reflecting the genetic complexity of T-ALL at diagnosis. The line expresses T cell surface markers consistent with T-ALL biology, making it relevant for studies of T lymphoblast leukemia pathogenesis and drug responses.

HPB-ALL is applicable in studies of T-ALL biology, TP53 multi-mutant phenotype, anti-leukemic drug sensitivity (glucocorticoids, vincristine, asparaginase, nelarabine), Notch and JAK-STAT pathway analysis, and comparative studies within the T-ALL cell line panel. It is suitable for in vitro pharmacological assays and xenograft models in immunocompromised hosts for preclinical T-ALL drug evaluation. Doubling time approximately 50 hours.

Audinys
Peripheral blood
Liga
Precursor T-cell acute lymphoblastic leukemia
Metastazių vieta
Peripheral blood (systemic T-ALL)
Paraiškos
T-ALL biology; TP53 multi-mutant phenotype; anti-leukemic drug sensitivity (glucocorticoids, vincristine, asparaginase, nelarabine); Notch/JAK-STAT pathways; xenograft models; T-ALL panel comparative studies
Sinonimai
  • HPB/ALL
  • HPBALL
  • FCCH1018

02Klasifikacija

Organizmas
Žmogus
Seksas
Vyras
Augimo savybės
Pakaba
Biologinio saugumo lygis
1

03Charakteristikos

Morfologija
Lymphoblast-like
Ląstelių tipas
T-cell
Laikas, per kurį skaičius padvigubėja
~50 hours

04Identifikatoriai

Nuoroda
HPB-ALL (Cytion catalog number 302895)
NCBI mokesčių identifikavimo kodas
9606
Cellosaurus
CVCL_1820

05Išraiška ir jautrumas

Mutacijų profilis
Mutation: p.Arg465His, Unspecified; Mutation: p.Ala134Ser, Unspecified; Mutation: p.Leu1574Pro, Heterozygous; Mutation: p.Asp2442fs*39, Heterozygous; Mutation: p.Arg159Ser, Unspecified; Mutation: p.Cys124Ter, Homozygous; Mutation: p.Arg273Cys, Unspecified; Mutation: p.Ser121Ter, Unspecified

06Laikymas ir auginimas

Maitinamoji terpė
RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
Maisto papildai
Supplement the medium with 10% FBS
Disociacijos reagentas
dilution
Subkultūrinis auginimas
Dilute the culture to 2–5 × 10⁵ cells/ml with fresh pre-warmed complete medium twice per week. No enzymatic dissociation required.
Skaidymo santykis
1 : 10 split
Sėjos tankis
3-5*10^5/ml
Skysčių atnaujinimas
Subculture : 2 times/week
Atšildymas ir auginimas
  1. Confirm that the vial remains deeply frozen upon delivery, as cells are shipped on dry ice to maintain optimal temperatures during transit.

  2. Upon receipt, either store the cryovial immediately at temperatures below -150°C to ensure the preservation of cellular integrity, or proceed to step 3 if immediate culturing is required.

  3. For immediate culturing, swiftly thaw the vial by immersing it in a 37°C water bath with clean water and an antimicrobial agent, agitating gently for 40-60 seconds until a small ice clump remains.

  4. Perform all subsequent steps under sterile conditions in a flow hood, disinfecting the cryovial with 70% ethanol before opening.

  5. Carefully open the disinfected vial and transfer the cell suspension into a 15 ml centrifuge tube containing 8 ml of room-temperature culture medium, mixing gently.

  6. Centrifuge the mixture at 200 x g for 5 minutes, carefully discard the supernatant containing freezing medium.

  7. Follow the procedure described under Post-Thaw Recovery

07Kokybės kontrolė ir kriokonservavimas

Šaldymo terpė
As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability.
Laikymo sąlygos

For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen.

Pristatymo sąlygos

Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage.

08Donoras

Donoro amžius
14 years
Etninė priklausomybė
Japanese

10Produkto aprašymas

Sudėties lentelė